Cipla targeting 10-12% growth in next 2-3 years
India's third largest pharmaceutical company Cipla is targeting 10-12 percent growth in the domestic market in the next two to three years, according to Ripples Advisory its newly elected Managing Director and Global Chief Executive Umang Vohra said ,Cipla will be targeting its three main markets — India, US and South Africa — for growth.
Increased R&D as well as better product mix is expected to aid the growth. Speaking at the company's 80th Annual General Meeting, that Cipla has improved its turnover by 16 percent in the last five years. As per a recent report in the ET, Cipla is targeting USD 1 billion sales by 2020.
Get live News Updates visit us at Ripples Advisory or One Missed Call on @98-27-80-80-90
India's third largest pharmaceutical company Cipla is targeting 10-12 percent growth in the domestic market in the next two to three years, according to Ripples Advisory its newly elected Managing Director and Global Chief Executive Umang Vohra said ,Cipla will be targeting its three main markets — India, US and South Africa — for growth. 
No comments:
Post a Comment